Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Legend Biotech Corp

ClinicalTrials.gov lists Legend Biotech Corp as lead sponsor of 10 trials, counting the companies grouped under it.

US Industry Manufacturer CIK 0001801198
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 2 Disease areas Disease areas 1 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 4 SEC-reported annual financials SEC-reported annual financials 9 Financing and grant events Financing and grant events 68 Manufacturing and distribution sites Manufacturing and distribution sites 1 Climate targets, as filed Climate targets, as filed 1 Companies grouped under this page Companies grouped under this page 2 Disease areas Disease areas 1 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 4 SEC-reported annual financials SEC-reported annual financials 9 Financing and grant events Financing and grant events 68 Manufacturing and distribution sites Manufacturing and distribution sites 1 Climate targets, as filed Climate targets, as filed 1

Rows recorded per section (log scale)

3 more sections with rows · 13 sections measured, none recorded

This page covers Legend Biotech Corp and 2 companies grouped under it: 10 lead-sponsored trials (0 its own, 10 in the grouped companies) and 2 legal-entity registrations (2 its own, 0 in the grouped companies).

Get the Legend Biotech Corp report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (2)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
Nanjing Legend Biotech Co. 7 0
Legend Biotech USA Inc 3 0

Disease areas (1)

Disease areas
Disease area Trials
Multiple Myeloma 1

Trials by start year as sponsor or collaborator (1)

Trials by start year as sponsor or collaborator
Year Trials started
2019 1

No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Journals published in (4)

Shown in this order: most published in first.

Journals published in
Journal Publications
Advances in therapy 4
Leukemia 2
Clinical lymphoma, myeloma & leukemia 1
Haematologica 1

SEC-reported annual financials (9)

Shown in this order: newest fiscal year first; SEC EDGAR XBRL companyfacts, USD as reported.

SEC-reported annual financials
Fiscal year Revenue (USD) Net income (USD) R&D (USD)
2025 1,028,900,000 -296,800,000 414,700,000
2024 627,300,000 -177,000,000 413,500,000
2023 285,100,000 -518,300,000 382,200,000
2022 117,005,000 -446,349,000 335,648,000
2021 68,826,000 -403,582,000 313,346,000
2020 75,000,000 -266,373,000 232,160,000
2019 57,264,000 -132,972,000 161,943,000
2018 49,133,000 -2,784,000 60,637,000
2017 not reported not reported not reported

Financing and grant events (68)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2026-06-17 Public offering not disclosed Sec extracted
2026-05-12 Other financing not disclosed Sec extracted
2026-04-30 Royalty / licensing not disclosed Sec extracted
2025-11-12 Private placement 760,000,000 Sec extracted
2025-11-12 Debt financing not disclosed Sec extracted

Showing 5 of 68 events.

Start your 14-day trial Email me the first 50 events as a PDF

Manufacturing and distribution sites (1)

Manufacturing and distribution sites
Facility Location Regulators Member organization
LEGEND BIOTECH USA INC. Raritan, US EMA, FDA, Health Canada Legend Biotech USA Inc.

Climate targets, as filed (1)

Climate targets, as filed
Reporting year Net-zero target
2025 not disclosed

Workforce and board diversity, as filed (1)

Workforce and board diversity, as filed
Reporting year Workforce % women Board % women
2025 not disclosed not disclosed

Organization relationships (1)

Organization relationships
Related organization Relationship Evidence
Johnson & Johnson Co sponsors trial with 1

Latest dated events (82)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-06-17 Public offering Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-05-12 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-04-30 Royalty / licensing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-11-12 Private placement Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-11-12 Debt facility Funding rounds and grants (NIH RePORTER + SEC EDGAR)

Showing 5 of 82 events.

Start your 14-day trial Email me the first 50 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.